Abnormal dopamine receptor signaling allows selective therapeutic targeting of neoplastic progenitors in AML patients

Authors:

Abstract
No abstract available
Funding Information
  • McMaster University (NCT02096289)
  • Canada Research Chairs
  • Canadian Cancer Society Research Institute (706694)

This publication has 65 references indexed in Scilit: